Oophorectomy, estrogen, and dementia: a 2014 update

Area of Science:

• Neuroscience
• Endocrinology
• Gerontology

Background:

• Estrogen's impact on brain health varies with age and menopausal stage.
• Bilateral oophorectomy before menopause is linked to increased cognitive decline and dementia risk.
• The timing hypothesis suggests estrogen's effects depend on when treatment is initiated.

Purpose of the Study:

• To review evidence on estrogen's neuroprotective effects concerning cognitive decline and dementia.
• To evaluate the role of menopausal stage and age in estrogen's effects on the brain.

Main Methods:

• Review of current evidence, including observational studies and clinical trials (Women's Health Initiative).
• Analysis of studies comparing women with and without oophorectomy before menopause.
• Examination of research investigating estrogen treatment (ET) initiation timing in postmenopausal women.

Main Results:

• Early estrogen exposure (natural or treatment before age 50) appears neuroprotective.
• Estrogen treatment initiated in late postmenopause (ages 65-79) increased dementia risk.
• Evidence supports the timing hypothesis: estrogen's effects are stage- and age-dependent.

Conclusions:

• Hormonal treatment may benefit women with premature or early menopause before age 50.
• Estrogen's role in typical menopause requires further research due to conflicting evidence.
• Age at initiation and menopausal stage are critical factors for estrogen's neuroprotective or detrimental effects.